Techno Drugs Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Net Income	222.71	280.6	195.51	479.78
Depreciation & Amortization	351.19	351.19	318.4	273.13
Other Operating Activities	-198.67	0.38	53.81	21.63
Change in Accounts Receivable	-169.25	-169.25	-82.53	-224.72
Change in Inventory	82.27	82.27	-292.5	-184.72
Change in Accounts Payable	-20.32	-20.32	44.37	69.51
Change in Other Net Operating Assets	-96.94	-96.94	-26.95	158.44
Operating Cash Flow	170.98	427.93	210.1	593.05
Operating Cash Flow Growth	-18.62%	103.68%	-64.57%	-
Capital Expenditures	-783.71	-344.3	-626.37	-594.57
Sale (Purchase) of Intangibles	-	-0.09	-5.05	-
Investment in Securities	18.19	5.88	-22.62	194
Investing Cash Flow	-765.53	-338.51	-654.04	-400.57
Short-Term Debt Issued	-	-	333.28	-
Long-Term Debt Issued	-	252.31	21.38	56.59
Total Debt Issued	483.2	252.31	354.65	56.59
Short-Term Debt Repaid	-	-267.75	-	-121.01
Long-Term Debt Repaid	-	-19.44	-10.06	-20.05
Total Debt Repaid	-434.72	-287.19	-10.06	-141.06
Net Debt Issued (Repaid)	48.48	-34.88	344.59	-84.46
Issuance of Common Stock	1,000	261.54	-	-
Other Financing Activities	-36.18	-29.47	-6.11	-5.63
Financing Cash Flow	962.91	197.19	338.48	-90.09
Miscellaneous Cash Flow Adjustments	-0	-	-	-0
Net Cash Flow	368.37	286.61	-105.47	102.39
Free Cash Flow	-612.73	83.64	-416.28	-1.52
Free Cash Flow Margin	-19.60%	2.31%	-15.23%	-0.03%
Free Cash Flow Per Share	-4.96	0.88	-4.42	-0.02
Cash Interest Paid	321.3	322.87	252.1	5.63
Cash Income Tax Paid	-	88.99	15.85	155.24
Levered Free Cash Flow	-	47.09	-468.59	-
Unlevered Free Cash Flow	-	238.3	-303.67	-
Change in Working Capital	-204.24	-204.24	-357.61	-181.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.